Oral tolerance prevents pathological inflammatory responses to innocuous foreign antigens by peripheral regulatory T cells (pT reg cells). However, whether a particular subset of antigen-presenting cells (APCs) is required during dietary antigen exposure for the 'instruction' of naive CD4 + T cells to differentiate into pT reg cells has not been defined. Using myeloid lineage-specific APC depletion in mice, we found that monocyte-derived APCs were dispensable, while classical dendritic cells (cDCs) were critical, for pT reg cell induction and oral tolerance. CD11b − cDCs from the gut-draining lymph nodes efficiently induced pT reg cells and, conversely, loss of transcription factor IRF8-dependent CD11b − cDCs impaired their polarization, although oral tolerance remained intact. These data reveal the hierarchy of cDC subsets in the induction of pT reg cells and their redundancy during the development of oral tolerance.
The peripheral immune system must maintain a balance between protective responses and tolerance. This equilibrium represents a major challenge for the mucosal surfaces, particularly the intestine, which is chronically exposed to both potentially pathogenic microbes and harmless dietary and commensal-derived antigens. Not surprisingly, several cellular and molecular mechanisms exist to ensure robust tolerance induction in the mucosae.
Peripherally induced Foxp3 + regulatory T cells (pT reg cells) are thought to be instrumental in the induction and maintenance of peripheral tolerance [1] [2] [3] [4] . Exposure to innocuous antigens via mucosal surfaces efficiently induces the differentiation of naive CD4 + T cells into pT reg cells via a process dependent on retinoic acid (RA) and the cytokine TGF-β 2,5-8 . In turn, genetic loss-of-function strategies that target pT reg cells result in severe inflammatory phenotypes in the lungs and intestine 3, 4 .
Antigen-presenting cells (APCs), including dendritic cells (DCs) and macrophages, have been ascribed critical roles in triggering pT reg cell differentiation [6] [7] [8] [9] [10] . In particular, intestinal APCs expressing the fractalkine receptor CX3CR1 take up soluble luminal antigens 11, 12 and, under certain conditions, migrate to the mesenteric lymph nodes (mLNs), where they present antigens to naive T cells 13 . In addition, CX3CR1-expressing phagocytes seem to transfer antigens to neighboring migratory DCs 11 , and these DCs are believed to induce the conversion of naive CD4 + T cells into pT reg cells after they migrate to the mLNs 14, 15 . Indeed, both lamina propria-derived DCs and mLNderived DCs, particularly integrin α E (CD103)-positive or DEC205 + DCs, produce large amounts of RA and TGF-β and efficiently induce pT reg cells 1, [6] [7] [8] [16] [17] [18] [19] . However, whether these pT reg cell-inducing APCs are also required for the induction of oral tolerance has not been investigated. Furthermore, because the strategies used so far that rely on cell surface markers have targeted multiple APC lineages, the exact nature and origin of APCs responsible for the induction of pT reg cells in vivo are still unclear.
Here we identified an essential role for pre-DC-derived classical dendritic cells (cDCs) for the induction of both pT reg cells and oral tolerance, while macrophages and monocyte-derived cells seemed to be dispensable for this. Furthermore, we identified a hierarchical pattern for the pT reg cell-inducing capacity of mLN-derived cDC subsets, whereby dietary antigen-mediated polarization of pT reg cells was the most dependent on migratory CD11b − cDCs dependent on the transcription factor IRF8. Oral tolerance was intact, however, in absence of this cDC subset, which highlights the robustness of this process and the functional redundancy of cDCs.
RESULTS

Break in oral tolerance in the systemic absence of cDCs
We first set out to determine whether one of the two main myeloid lineages, the macrophage-monocyte lineage or the common DC precursor lineage, was required for the induction of oral tolerance (Supplementary Fig. 1a ). Throughout our study, we focused on the populations present in the mLNs, the main inductive sites of oral tolerance 14 . The macrophage-monocyte lineage in mLNs is dominated by macrophages, identified as Lin − MHCII + CD11c + CD64 + cells; the common DC precursor lineage is represented by cDCs, identified as Lin − MHCII + CD11c + CD64 − cells 20 (Fig. 1a) . Among cDCs, we distinguished between two resident MHCII int populations A r t i c l e s (CD8α + CD11b lo versus CD8α − CD11b + ) and two migratory MHCII hi populations (CD103 + CD11b − versus CD103 + CD11b + ) ( Fig. 1a) . We first used a mouse model of delayed-type hypersensitivity of the T H 1 subset of helper T cells 9 to address whether a specific APC lineage was required for the induction phase of oral tolerance. Tolerance was assessed by measurement of the cellular and humoral inflammatory immune response to ovalbumin (OVA) in mice preexposed to oral OVA or oral PBS (as a control) and immunized with OVA in complete Freund's adjuvant (CFA) (Fig. 1b) . We targeted the macrophage-monocyte lineage through the use of 'MM DTR mice' (which express the gene encoding Cre recombinase under control of the myeoid cell-specific Lyz2 promoter (Lyz2 Cre ) and sequence encoding the diphtheria toxin receptor (DTR) gene preceded by a loxP site-flanked stop cassette under control of the macrophagespecific Csf1r promoter (Csf1r LsL-DTR )) 20 . We targeted the pre-DC-derived lineage through the use of 'zDC DTR mice' (which have sequence encoding DTR knocked in 3′ of Zbtb46, which encodes a transcription factor (Zbtb46) of the pre-DC lineage (Zbtb46 DTR )) 21 . Because diphtheria toxin (DT) is lethal to zDC DTR mice, due to the expression of Zbtb46 in vascular endothelium 21 , we used chimeras generated by the transfer of total bone marrow (BM) cells from zDC DTR or MM DTR mice or DTR-negative control mice (called 'wild-type' mice here) into lethally irradiated C57BL/6 mice. The administration of DT to the resultant MM DTR chimeras led to broad depletion of monocytes, monocyte-and yolk sac-derived tissue macrophages and inflammatory DCs, which lasted for at least 36 h (ref. 20) (Supplementary Fig. 1b,c) , while the administration of DT to the resultant zDC DTR chimeras resulted in a compensatory surge in the cytokine Flt3L in the serum, as well as a complete loss of cDCs, including migratory cDC subsets in the mLNs 20 ( Supplementary  Fig. 1c,d) . To induce oral tolerance, we fed OVA to mice by gavage ('OVA gavage') at 12 and 30 h after the first of three DT injections given 36 h apart, while mice fed PBS served as non-tolerant controls, and we timed the administration of DT and OVA or PBS such that the clearance of OVA (completed after 24 h) preceded the reappearance of APCs 20 (Supplementary Fig. 1e-h) . We ruled out the possibility that the administration of DT to the chimeras resulted in altered absorption of oral antigen, as we observed similar uptake of OVA into various tissues in DT-treated zDC DTR , MM DTR and wild-type mice at 4 h after OVA gavage ( Supplementary Fig. 1i-m) . Because APCs are required for immune responses, we immunized mice with OVA plus CFA 8 d after the final DT dose, when the APC niches were replenished ( Fig. 1b and Supplementary Fig. 1n,o) , followed by subcutaneous injection of OVA in the ear 14 and 24 d after immunization.
At 72 h after the injection of OVA into the ear, ear swelling and serum titers of anti-OVA immunoglobulin G1 (IgG1) and anti-OVA IgG2c were lower in OVA-fed wild-type and MM DTR , but not in OVA-fed zDC DTR chimeras, than in their PBS-fed counterparts ( Fig. 1c-e ). We noticed that PBS-fed zDC DTR chimeras immunized with OVA in CFA produced less serum IgG than did their wild-type or MM DTR counterparts, probably a consequence of the overall reduced frequency of CD4 + T cells after recent depletion of cDCs ( Supplementary Fig. 1o ). As a positive control for the APC dependence of oral tolerance induction, we also studied chimeras lacking all CD11c-expressing APCs 20, 22 , generated by the transfer of BM from mice expressing the DTR under control of the promoter of Itgax, which encodes the integrin and common APC marker CD11c ('CD11c DTR mice'), into lethally irradiated C57BL/6 mice (to generate 'CD11c DTR chimeras') 20, 22 . PBS-fed and OVA-fed CD11c DTR chimeras showed similar ear swelling and serum anti-OVA immunoglobulin responses ( Fig. 1c-e ), which suggested a lack of tolerance to OVA. These observations indicated that monocytemacrophage-derived APCs were dispensable for oral tolerance induction, while pre-DC-derived cells were critical for this.
Next we assessed the requirement for cDCs in preventing allergic responses of the T H 2 subset of helper T cells 2 . Following the same regimen used for the administration of DT and oral OVA described above, we immunized mice with OVA in the adjuvant alum at 8 and 15 d after the final injection of DT and challenged the mice intranasally with OVA three times at 3-day intervals ( Fig. 2a) . Eosinophilia in the bronchoalveolar lavage fluid and lungs, as well as total lung-tissue cellular infiltrates and serum IgE, were similarly lower in OVA-fed wild-type and MM DTR chimeras, but not in OVA-fed zDC DTR chimeras, than in the corresponding PBS-fed chimeras ( Fig. 2b-g) . These data showed that the absence of cDCs during antigen feeding resulted in a failure to establish tolerance to both T H 1 immunity and T H 2 immunity.
Requirement for cDCs in pT reg cell induction
Oral tolerance is mediated by pT reg cells 2,3 . We thus addressed whether the pre-DC lineage was required for the induction of pT reg cells after antigen feeding by adoptively transferring sorted naive CD45. Figure 1 Delayed-type hypersensitivity responses in mice depleted of APC subsets during antigen feeding. (a) Flow cytometry of macrophages and cDC subpopulations in the mLNs of wild-type mice. Numbers adjacent to outlined areas indicate percent cells in each. MΦ, macrophage. (b) Experimental design for the establishment of oral tolerance to CFA-mediated immunity. BMC, BM chimera; sc, subcutaneous. (c) Degree of ear swelling 48 h after the second subcutaneous OVA challenge (as in b) in wild-type (WT), MM DTR , zDC DTR and CD11c DTR chimeras (horizontal axis) treated with DT during oral exposure to OVA or PBS (key). (d,e) Serum concentrations of anti-OVA IgG1 (e) and anti-OVA IgG2c (e) in the mice in c at 28 d after immunization with OVA-CFA (as in b). AU, arbitrary units. Each symbol (c-e) indicates an individual mouse. NS, not significant (P > 0.05); *P < 0.01 and **P < 0.005 (two-tailed t-test). Data are pooled from two independent experiments (average ± s.e.m. of n = 10 mice per group in c-e).
npg OVA-specific OT-II cells into CD45.2 + BM chimeras (generated as described above) depleted of APCs, then assessing the appearance of CD45.1 + (donor) Foxp3 + T cells in various tissues after the administration of OVA by gavage ( Fig. 3a) . The administration of DT alone did not induce the activation, proliferation or differentiation of OT-II cells in the chimeric host mice (data not shown). At 48 h after the initial oral administration of OVA, MM DTR chimeric host mice displayed compromised (but perceptible) induction of pT reg cells in mLNs compared with that of wild-type chimeric host mice (Fig. 3b,c) , an effect that was accompanied by an unaltered degree of OT-II cell engraftment but reduced overall activation and division of OT-II cells ( Fig. 3b-f and Supplementary  Fig. 2a ). In contrast, pT reg cells were almost completely undetectable in OVA-fed zDC DTR chimeric host mice (Fig. 3b,c) , and the activation of OT-II cells was decreased compared with that of OVA-fed wild-type chimeric host mice (Fig. 3e) . The engraftment of OT-II cells was lower in zDC DTR chimeric host mice than in wild-type chimeric host mice ( Fig. 3d) , an observation we also made after the administration of DT alone (Supplementary Fig. 2b ). At this time point we did not find substantial activation of OT-II cells or induction of pT reg cells in the spleen or distal lymph nodes of any of the groups studied (data not shown). The effect of the depletion of monocytes-macrophages on the induction of pT reg cells was compensated for over time, as by 7.5 d after OVA feeding, the frequency of pT reg cells in MM DTR chimeric host mice was similar to that of their wild-type counterparts ( Fig. 3g) , in line with the intact tolerance found in these MM DTR chimeric mice (Figs. 1c-e and 2b-g). In zDC DTR chimeric host mice, the frequency of OT-II cells 7.5 d after OVA gavage were proportional to the CD4 + T cell compartment ( Supplementary Fig. 2c) ; however, the frequency of pT reg cells among the transferred cells was still substantially reduced in the mLNs ( Fig. 3g and Supplementary Fig. 2d,e ), spleen and distal lymph nodes (data not shown) compared with the induction of pT reg cells in wild-type chimeric hosts. These data indicated that the activation and proliferation of CD4 + T cells and the induction of pT reg cells depended on cDCs and excluded the possibility of an essential contribution of monocyte-derived APCs to the generation of pT reg cells after oral exposure to antigen.
Contribution of CX3CR1 + APCs to pT reg cell polarization in mLNs
Here we distinguished APC subsets by ontogeny, but other studies have ascribed roles to gut-associated APCs on the basis of CX3CR1targeting approaches 9, 11, 13, 23 . To define the lineage of origin of CX3CR1-expressing APC populations in steady-state mLNs, we generated chimeras by transferring BM from the progeny of Cx3cr1 +/GFP mice (with heterozygous expression of green fluorescent protein (GFP) from Cx3cr1) crossed to zDC DTR , MM DTR or wild-type control mice into lethally irradiated C57BL/6 mice, then injected DT into the resultant chimeras and characterized their loss of GFP + cells. GFP + cells represented roughly 25% of all CD11c + APCs in the mLNs (Fig. 4a,b) . The results obtained by the administration of DT to MM DTR Cx3cr1 +/GFP chimeras indicated that most monocytemacrophage-derived cells were among the GFP + cells (Fig. 4b,c ). In addition to CD64 + macrophages, about half of CD8α + and CD11b + cells, and roughly 20% of CD103 + CD11b − populations, among the GFP + cells underwent depletion via DT in MM DTR Cx3cr1 +/GFP chimeras ( Fig. 4b,c) , which indicated that a portion of the GFP + CD64 − cells were of monocyte-macrophage origin. Notwithstanding those results, targeting of DT in zDC DTR Cx3cr1 +/GFP chimeras revealed that cDC-derived cells represented the majority of APCs among CX3CR1 + 
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A r t i c l e s (Fig. 4b,c) . These analyses highlighted the heterogeneity of CX3CR1 expression by APC subsets. Microbiota-derived signals have been linked to regulation of the migration of CX3CR1 hi mononuclear phagocytes 13 . To better characterize these cells, we transplanted BM from zDC DTR Cx3cr1 +/GFP or wild-type Cx3cr1 +/GFP mice into lethally irradiated germ-free (GF) or specific pathogen-free (SPF) wild-type host mice. We found a selective expansion of the CD103 + CD11b + population in the mLNs of all GF chimeric host mice relative to its size in the SPF host mice, regardless of the genotype of the BM transferred ( Fig. 4d and Supplementary  Fig. 3a) . However, we observed the same fraction of CX3CR1 + cells among CD103 + CD11b + cells in GF and SPF chimeric host mice (data not shown), which indicated that the enrichment could not be explained by specific mobilization of CX3CR1 + cells. Depleting the mice of cDCs indicated that CD11c + CD64 − cells, including migratory subsets, remained pre-DC derived in the zDC DTR Cx3cr1 +/GFP GF chimeras ( Fig. 4d and Supplementary Fig. 3b ).
Finally, we sought to determine whether the altered cDC composition in the GF chimeras had an effect on the induction of pT reg cells by analyzing the fate of adoptively transferred OT-II cells upon OVA gavage in these mice relative to the fate of such cells in their SPF counterparts. The GF chimeric hosts displayed reduced induction and cell division of pT reg cells compared with that of SPF chimeric hosts, and the administration of DT completely prevented the appearance of Foxp3 + OT-II cells in both zDC DTR Cx3cr1 +/GFP GF hosts and zDC DTR Cx3cr1 +/GFP SPF hosts (Fig. 4e) . The number of CD4 + T cells and engraftment of OT-II cells was lower in DT-treated zDC DTR Cx3cr1 +/GFP chimeric host mice than in Cx3Cr1 +/GFP chimeric host mice, and the degree of this reduction was the same in the GF condition and SPF condition ( Supplementary Fig. 3c,d) . These data indicated that the composition of APCs in GF mice was less favorable for the induction of pT reg cells than was the composition of APCs in SPF mice and that the remaining APCs in GF hosts depleted of cDCs was not able to improve the blunted induction of pT reg cells observed in zDC DTR Cx3cr1 +/GFP SPF mice.
To further reconcile our lineage-based approach with CX3CR1targeting strategies and address the role of CX3CR1 + APCs in the induction of pT reg cells, we performed experiments in which we adoptively transferred OT-II cells into lethally irradiated C57BL/6 recipients of Itgax Cre × Cx3cr1 LsL-DTR (CX3CR1 DTR ) BM (to generate 'CX3CR1 DTR host chimeras') or Cx3cr1 LsL-DTR ('wild-type' control) BM (to generate 'wild-type host chimeras') 13 . In CX3CR1 DTR mice, expression of Cre recombinase is under control of the Itgax promoter, while the sequence encoding DTR is preceded by a loxP site-flanked stop cassette under control of the Cx3cr1 promoter, which allows DTmediated depletion of (CD11c + ) CX3CR1 + cells for at least 48 h (ref. 13) . As reported before 13 , the administration of DT to CX3CR1 DTR chimeric hosts led to depletion of mLN macrophages (CD11c + CD64 + cells), although it also depleted CD11c + CD64 − cells (Fig. 4f) . The degree of depletion in each APC subset ( Fig. 4g ) correlated with the frequency of CX3CR1 + cells in these subsets ( Fig. 4a-c) . In line with that pleiotropic targeting of APCs, the induction of pT reg cells from adoptively transferred naive OT-II cells at 48 h after gavage of OVA was reduced more in DT-treated CX3CR1 DTR chimeric hosts than in DT-treated MM DTR chimeras, relative to that of their respective wild-type (control) counterparts ( Figs. 4h and 3c) , while the activation and division of OT-II cells were affected only mildly, and the number of CD4 + T cells and engraftment of OT-II cells were not altered, relative to that of their wild-type counterparts ( Fig. 4i and Supplementary Fig. 3e,f) . However, similar to the results obtained for MM DTR chimeric mice, the frequency of pT reg cells and division of OT-II cells were restored to wild-type levels by day 7.5 after gavage of OVA ( Fig. 4i,j) . Together these results suggested that CX3CR1expressing macrophages were not essential for the generation of pT reg cells by dietary antigen, while cDCs were required for this; they also highlight the merits of a lineage-based approach for delineation of the differential contributions of APCs to the induction of pT reg cells and oral tolerance.
Differential molecular signatures of cDCs
Published studies have described pT reg cell-inducing DC populations in mouse gut and gut-draining lymph nodes [6] [7] [8] 10, 16 . Additionally, large transcriptome databases for specific cDC populations have been made available [24] [25] [26] . However, those studies did not compare IRF4-versus IRF8-dependent DC populations (distinguishable by CD8α − CD11b + or CD8α + CD11b − staining, respectively) among resident (CCR7 − or MHCII int ) and migratory (CCR7 + or MHCII hi ) DC populations. To obtain a higher resolution of the cDC subsets and to link them with their lineage of origin, we performed RNA sequencing (RNA-seq) of cDCs present in the mLNs. We analyzed four CD11c + CD64 − subsets: mLN-resident MHCII int (CD8α + CD11b lo CD103 + or CD8α − CD11b + CD103 − ) subpopulations and migratory MHCII hi (CD11b − CD103 + or CD11b + CD103 + ) subpopulations. Plasmacytoid DCs (pDCs) were not evaluated due to their very low abundance and the fact that these cells are not targeted in zDC DTR chimeras after the administration of DT. Of note, we npg observed that the relative frequencies of cDC and lymphocyte subsets were similar in the various lymph nodes draining the proximal to distal gastrointestinal tract ( Supplementary Fig. 4a-m) , and therefore we subjected cDCs sorted from total mLN pools to expression profiling. Unsupervised principle-component analysis revealed that resident and migratory cDC subsets were the populations most segregated ( Supplementary Fig. 4n ), while IRF8-and IRF4-dependent subsets followed a hierarchical pattern in their tolerance-inducing gene expression. Thus, migratory, IRF8-dependent CD103 + CD11b − DCs had the highest expression of Aldh1a2 (which encodes the retinaldehyde dehydrogenase RALDH2), as well as Tgfb2 (which encodes the cytokine TGF-β2), Itgb8 (which encodes the integrin β 8 ) and several other genes encoding products associated with generation of pT reg cells and homing to the gut (Fig. 5a-c and Supplementary Fig. 4o,p) . This gene signature was progressively lost in the CD8α + and CD103 + CD11b + populations, which instead expressed genes encoding other isoforms of TGF-β and RALDH; CD11b + DCs had the lowest expression of these genes (Fig. 5a-c and Supplementary Fig. 4o,p) . This hierarchy was confirmed by the activity of RALDHs in cDCs freshly isolated from total mLNs (Fig. 5d) . In contrast, CD103 + CD11b − DCs did not express genes encoding typical pro-inflammatory products, although Il12b (which encodes npg A r t i c l e s Ikbkg  Tollip  Tlr9  Irak1  Mapk8  Map3k1  Ikbkb  Map3k14  Rela  Nfkbia  Tab2  Traf6  Eif2ak2  Tirap  Cd14  Fos  Tlr3  Map2k6  Map2k3  Myd88  Jun  Tlr2  Nfkb1  Elk1  Ecsit  Mapk14  Pglyrp1  Tab1  Nod2  Nod1  Tlr5  Tlr7  Tlr4  Tlr6 Tlr8 Ppara the cytokine IL-12p40) was 'preferentially' expressed in these cells relative to its expression in the other DC populations ( Supplementary  Fig. 4q ). However, transcripts of Il12a (which encodes IL-12p35) or Il23a (which encodes IL-23p19) were not present in the absence of inflammatory triggers (Supplementary Fig. 4q ). While CD11b + DCs had the lowest expression of the pT reg cell-inducing gene signature, they had the highest expression of genes encoding products associated with pathogen sensing and the initiation of inflammatory responses, including TLRs and TLR-signaling molecules (Fig. 5a,e) , and they had a distinct cytokine-expression profile (Supplementary Fig. 4q ). This expression profiling indicated that IRF8-dependent cDCs were the main tolerogenic subsets in the mLNs.
Effect of Zbtb46-driven targeting of Irf8 on pT reg cell induction Several strategies have been devised in the past to ablate CD11b − DCs dependent on the transcription factors IRF8 and BATF3 (refs. 27-30), but some approaches have led to defects beyond those caused by the loss of cDC subsets 28, 31 . Additional cDC-specific genetic approaches have been reported 32, 33 , and they have revealed the reliance of helper T cell polarization on certain DC populations 20 . However, whether a specific cDC subset is necessary for the induction of pT reg cells and oral tolerance has not been addressed. We therefore generated a mouse strain expressing Cre under control of the endogenous Zbtb46 promoter ('zDC Cre mice') 34 and crossed those to mice with loxP siteflanking of Irf8 exon 2 (Irf8 fl/fl ), which encodes the DNA-binding domain of IRF8, to generate mice with cDC-specific Irf8 deficiency ('zDC(∆Irf8) mice') 35 . The zDC(∆Irf8) mice were viable, were born at Mendelian ratios, and exhibited normal weights and no visible pathology up to the age of 12 weeks (data not shown). This strategy led to the loss of CD8α + and CD11b − cDCs in the mLNs, lamina propria ( Fig. 6a-e ) and spleen (Supplementary Fig. 5a-c) of zDC(∆Irf8) mice in contrast to the presence of these cells in those tissues in Irf8 fl/fl mice, with no major effects on the frequency of T cells or B cells (Fig. 6f,g and data not shown). We noticed that excision of Irf8 (ref. 35 ) led to variable loss of cDCs; however, since the degree of loss of CD8α + and CD11b − DCs was the same in lethally irradiated wild-type recipients of zDC(∆Irf8) BM as in the donor of the BM used (data not shown), BM transplantation preserved the degree of niche depletion and permitted the generation of large and uniform cohorts of mice deficient in CD8α + and CD11b − cDCs. We therefore transplanted BM from zDC(∆Irf8) or Irf8 fl/fl mice into lethally irradiated wild-type host mice to assess the importance of IRF8-dependent cDCs in oral tolerance (Fig. 1b , excluding DT injection). We found that ear swelling and titers of IgG1 and IgG2c in the serum were suppressed to a similar degree in OVA-fed zDC(∆Irf8) or Irf8 fl/fl chimeras compared with such results obtained for their PBS-fed counterparts (Fig. 7a-c) . We observed this apparently intact tolerance in zDC(∆Irf8) chimeras even when we immunized them with OVA plus CFA 24 h after the first oral antigen encounter, to blunt potential compensatory population expansion of pT reg cells (data not shown).
Next, we directly assessed the importance of IRF8-dependent cDCs for the polarization of pT reg cells after the administration of oral antigen in vivo. We adoptively transferred naive OT-II cells into zDC(∆Irf8) and Irf8 fl/fl chimeras and treated them as described above (Fig. 3a , excluding injection of DT). At 48 h after first oral encounter with OVA, the induction of pT reg cells among adoptively transferred naive OT-II cells was lower in zDC(∆Irf8) chimeric hosts than in Irf8 fl/fl chimeric hosts, while the division of OT-II cells was significantly greater in zDC(∆Irf8) chimeric hosts than in Irf8 fl/fl chimeric hosts ( Fig. 7d-f) . This phenomenon persisted in the mLNs, spleen and other peripheral lymph nodes at 7.5 d after mice were fed OVA ( Fig. 7g and data not shown) . OT-II cells did not produce substantial amounts of the cytokines IFN-γ, A r t i c l e s IL-5 or IL-17a under these conditions, and this was not greater in zDC(∆Irf8) chimeric hosts than in Irf8 fl/fl chimeric hosts (data not shown). These findings were in line with loss of the migratory and resident mLN DC subsets with the most tolerogenic signatures. However, the impairment in the induction of pT reg cells was less severe in zDC(∆Irf8) chimeric hosts (Fig. 7d,g) than in zDC DTR chimeric hosts (Fig. 3c) . These results demonstrated that the targeting of IRF8-dependent cDCs partially prevented the generation of pT reg cells in vivo but did not affect oral tolerance, which indicated that the remaining cDC pools and pT reg cells could have compensated for loss of the IRF8-dependent DC lineage during the development of oral tolerance.
Hierarchical roles of cDCs in pT reg cell induction
To gain insight into early changes 'imprinted' on T cells by different DC populations, we isolated cDC subsets from the mLNs of C57BL/6 mice, then cultured OT-II cells together with the cDCs and OVA peptide and performed RNA-seq analysis of the activated OT-II cells after 24 h of co-culture. Unsupervised principle-component analysis indicated that OT-II cells stimulated by resident and migratory cDC subsets were the populations most segregated (Supplementary Fig. 6) , analogous to the clustering of DC subsets (Supplementary Fig. 4n) . The various cDC subsets induced a hierarchical pT reg cell pattern in OT-II cells (Fig. 8a) . Consistent with the cDC gene profile (Fig. 5a-c) , and with a process initiated by the TGF-β and RA pathways [6] [7] [8] 16, 17, 36 , naive T cells upregulated genes encoding several pT reg cell-and gut homing-associated products when exposed to CD103 + CD11b − DCs; CD103 + CD11b + and CD8α + DCs induced an intermediary phenotype; and CD11b + DCs were the least able to trigger this signature (Fig. 8a,b) . The pT reg cell-polarizing capacity of mLN cDCs subsets was confirmed in co-culture experiments 6 : CD11b − CD103 + cells were the most efficient inducers, followed by CD8α + cells, CD11b + CD103 + cells and CD11b + CD103 − cells (Fig. 8c) , results that closely mirrored the transcriptome analyses of the cDC subsets ( Fig. 5a-c) and OT-II cells (Fig. 8a,b) . Although the frequency of activated OT-II cells was similar in co-cultures with the various DC subsets (data not shown), we found an inverse correlation between the induction of pT reg cells and the induction of proliferation among cDC subsets, whereby CD8α − CD11b + cells triggered the highest rate of cell division (Fig. 8c) .
Since the provision of antigen in vitro might obscure differences in antigen capture and processing that occur in vivo, we also assessed the polarization of pT reg cells in co-cultures with cDCs sorted from OVAfed mice. We found that CD11b − CD103 + cells consistently induced a higher frequency of Foxp3 + OT-II cells than did other cells, although other cDC subsets were also able to induce Foxp3 + cells (Fig. 8d) . Overall, the differences in pT reg cell-induction potential among the cDC subsets correlated with lineage but not strictly with expression of major histocompatibility complex class II (MHCII): CD11b − DC subsets provided superior pT reg cell-polarizing signals and inferior cell-cycling or pro-inflammatory signals relative to those provided by the CD11b + subsets, which corresponded to the IRF8-dependent cDC lineages and IRF4-dependent cDC lineages, respectively. In conclusion, we observed a hierarchical, but redundant, role for cDC subsets in the induction of pT reg cells and oral tolerance.
DISCUSSION
Here we have reported that pre-DC-derived APCs were required for both the generation of pT reg cells and oral tolerance, but monocytederived APCs were not. In addition, pre-DC-derived cDC subsets had partially redundant roles in these processes, with IRF8-dependent cDC populations being the main inducers of pT reg cells. Our high-resolution analysis of cDCs subsets identified a pT reg cell-inducing gene signature in the IRF8-dependent, MHCII hi CCR7 hi migratory cDC population, consistent with the established role of CD103 + DCs 6,10 in pT reg cell polarization. Through the use of ontogeny-based genetics, we have provided evidence to reconcile published observations defining APC requirements for the induction of pT reg cells, obtained by various cell surface-based targeting strategies. Because major APC subsets underwent depletion specifically only during exposure to oral antigen, our studies do not rule out the possibility of a role for monocyte-derived lineages or pDCs in the maintenance, population expansion and survival of pT reg cells during later phases of oral tolerance suggested before 9, 37 .
Cell-surface molecules such as CCR2, CD11c and CX3CR1 have been used as targets for the ablation of APC function, development or migration in multiple studies aimed at defining a role for these cells in the induction of pT reg cells 9, 11, 13, 15, 38, 39 . Given the high expression of CX3CR1 by intestinal APCs, two main strategies have targeted CX3CR1-expressing cells or Cx3cr1 itself 13, 23 . Receptor-targeting studies using Cx3cr1 GFP/GFP mice have indicated that CX3CR1 is necessary for the sampling and transfer of luminal antigens 11, 23 , which would suggest an essential role for fractalkine sensing in the function and/or localization of APCs. A study using cell-transfer strategies has concluded that CX3CR1 is required for macrophage-mediated population expansion of pT reg cells rather than the induction of pT reg cells 9 ; those results are not in contradiction with our observations. CX3CR1 hi APCs have been defined as lamina propria and mLN macrophages, while a fraction of DCs of pre-DC origin are reported to have low or intermediate expression of CX3CR1 (refs. 13, 32, [40] [41] [42] . A study targeting APCs by the administration of DT to CX3CR1 DTR mice has shown that while CX3CR1 hi mononuclear phagocytes undergo efficient deletion, CX3CR1 lo-int cells (non-macrophages) remain intact in the lamina propria 13 . Both by analysis of Cx3cr1 +/GFP reporter mice and lineage-depletion strategies, we determined the contribution of macrophages and cDC subsets to the CX3CR1 + pools in mLN and lamina propria. We observed depletion of both macrophages and CX3CR1-expressing cDCs in the mLNs of CX3CR1 DTR chimeras upon administration of DT. Regardless of the apparent targeting differences, we did not find sustained impairment in the induction of pT reg cells in CX3CR1 DTR chimeras given injection of DT, in line with our observation that monocyte-derived APCs were not strictly needed for oral antigen-mediated induction of pT reg cells. However, whether CX3CR1-expressing cells have a specific role in the maintenance of pT reg cells and oral tolerance or, alternatively, whether CX3CR1 expression is required for the functional and anatomical properties of cDCs are issues that remain to be resolved.
Lineage-based intersectional genetics also provided information about the hierarchy of cDC subsets in their pT reg cell-induction potential. IRF8-dependent cDCs and the CD8α + or CD103 + CD11b − cDC populations 43, 44 were highly efficient in the generation of pT reg cells. Our transcriptomics results confirmed and expanded published analyses 24, 25 , identifying much higher expression of genes related to the TGF-β and RA pathways in migratory CD103 + CD11b − DCs. Furthermore, while our data have confirmed published observations that CD103 + DCs are efficient inducers of pT reg cells via these pathways, they also identified the subpopulation among the three CD103 + DC populations in the mLNs (CD8α + CD11b lo CD103 + , CD11b − CD103 + and CD11b + CD103 + ) that governs this phenomenon. Parallel RNA-seq of T cells and cDCs also revealed cDC subsetspecific gene signatures that closely mirrored early gene programs induced in T cells, which further reinforced the conclusion of a role for these pathways in the generation of pT reg cells 2,4,6-8 .
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A r t i c l e s
In line with published studies addressing the role of IRF4 and the receptor Notch2 in the development of cDCs 26, [45] [46] [47] [48] , we observed that CD11b + DCs subsets were rather inefficient in the induction of pT reg cells, while they showed a superior capacity (relative to that of the other DC subpopulations) for inducing the population expansion and maintenance of CD4 + T cells and polarization toward helper T cells. The 'preference' of particular cDC subsets in inducing the differentiation of pT reg cells versus effector T cells was not absolute, as demonstrated by our Irf8-targeting approach that resulted in reduced generation of pT reg cells but intact oral tolerance. Our observations support those of published reports indicating a 'division of labor' among APC subsets 13, 49 . However, depletion of the microbiome, which has been shown to boost the migratory capacity of intestinal APCs 13 , did not 'rescue' the induction of pT reg cells in mice depleted of cDCs. Additionally, although migratory IRF8-dependent cDCs seemed to have the greatest capacity to induce pT reg cell differentiation in the mLNs, this subset was underrepresented in the lamina propria. That observation, along with the known cell-free antigen distribution through the intestinal draining lymph 50 , raises the possibility that antigen sampling and carriage might have only a limited effect compared with that of cell-independent pathways of antigen distribution; instead, what determines the degree of pT reg cell induction might be the composition of cDCs in the mLNs that capture antigen in situ. Therefore, characterization of the relative contributions of APC-mediated antigen delivery versus cell-free antigen delivery is a logical next step for such studies.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. GEO: RNA-seq data, GSE77305.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Mice. C57BL/6J CD45.1 (B6.SJL-Ptprca Pepcb/BoyJ) and CD45.2 (C57BL/6J), Lyz2 Cre/Cre (B6.129P2-Lyz2tm1(cre)Ifo/J), Cx3cr1 GFP (B6.129P(Cg)-Ptprca Cx3cr1tm1Litt/LittJ), Cx3cr1 LsL-DTR (B6N.129P2-Cx3cr1tm3(DTR)Litt/J), CD11c Cre (B6.Cg-Tg(Itgax-cre)1-1Reiz/J), CD11c DTR (B6.FVB-Tg(Itgax-DTR/ EGFP)57Lan/J) and Irf8 fl/fl (B6(Cg)-Irf8tm1.1Hm/J) mice were purchased from the Jackson Laboratories, and CD45.1 OT-II mice were originally purchased from Taconic Farms and maintained in our facilities. Csf1r LsL-DTR , zDC DTR and zDC Cre knock-in mice were generated in the Nussenzweig lab and shared with us 20, 21, 34 . These lines were interbred in our facilities to obtain the final strains described in the text. Genotyping was performed according to the protocols established for the respective strains by Jackson Laboratories. zDC Cre mice were screened for Cre using PCR primers: 5′-TTACCGGTCGATGCAACGAGT-3′ and 5′-TTCCATGAGTGAACGAACC-3′. Excision of the loxP-flanked Irf8 allele fragment was confirmed using Platinum DNA polymerase (Invitrogen) and primers 5′-TTGGGGATTTCCAGGCTGTTCTA-3′ and 5′-TCTACACAGGAAGCAAGCCG-3′, which give rise to ~2900 bp or ~1500 bp PCR product for the floxed or recombined locus, respectively. Mice were used at 7-12 weeks of age, and male mice were used throughout the study unless indicated otherwise. Mice were maintained at the Rockefeller University animal facilities under specific pathogen-free conditions or germ free conditions. Germ-free C57BL/6 mice were provided by S. Mazmanian (California Institute of Technology) and were imported into germ-free flexible film isolators (Class Biologically Clean Ltd.). The mice were bred in our germ-free facility for maintenance of the strain and kept on sterilized Autoclavable Mouse Breeder Diet (5021, LabDiet, USA), which was also used for control (ex germ-free) SPF mice. Animal care and experimentation were consistent with the NIH guidelines and were approved by the Institutional Animal Care and Use Committee at the Rockefeller University.
Antibodies and cell staining. Antibodies are described in Supplementary  Table 1 . Aqua LIVE/DEAD Fixable Aqua Dead Cell Stain Kit, L-34965, was purchased from Life Technologies. Horseradish peroxidase conjugated Streptavidin was purchased from Jackson ImmunoResearch Laboratories, Inc.
Lymphocyte and APC isolation from small intestine. Small intestines were separated from mesentery, and Peyer's patches and feces were removed. Intestines were cut longitudinally and washed twice in Magnesium and Calcium free HBSS+ 1 g/l glucose (HBSS) (Gibco), and once in HBSS plus 1 mM DTT (Sigma-Aldrich). Tissue was cut into 1 cm pieces and the epithelium removed by incubation in 25 ml of HBSS plus 2% FCS plus 1.3 mM EDTA for 15 min at 37 °C at 230 r.p.m. Tubes were vortexed, the intestinal pieces recovered in a sieve and washed for an additional 15 min in 25 ml of HBSS plus 2% FCS at 37 °C at 230 r.p.m. Tissues were then finely chopped and digested in 8 ml of RPMI (Gibco), 2% FCS, 200 µg/ml DNaseI (Roche) and 2 mg/ml Collagenase IV (Gibco) twice for 20 min at 37 °C in 5% CO 2 . After the first and second 20 min, digests were taken up and resuspended ten times. Final digests were passed through a sieve and the collagenase quenched by addition of 15 ml of cold RPMI, 2% FCS. Cell pellets were resuspended in 35% Percoll (BD Pharmigen), passed through a 100 µm mesh and separated by centrifugation in a discontinuous Percoll gradient (70%-35%) at 1,000g for 25 min at room temperature (RT). APCs and lymphocytes were isolated from the interphase, washed, and stained for flow cytometry.
Lymphocyte and APC isolation from lymph nodes and spleen. Tissues were dissected into cold HBSS supplemented with Mg 2+ and Ca 2+ , finely chopped and incubated in 400 U/ml Collagenase D (Roche) in HBSS for 25 min at 37 °C, 5% CO 2 . Collagenase was quenched on ice by addition of final 10% FCS. Single-cell suspensions were extracted from connective tissue by taking up and resuspending the digests five times. Erythrocytes were lysed by incubation in erythrocyte lysis buffer (Sigma) for 7 min at RT.
Segmentation of mesenteric lymph nodes.
Mesenteric lymph nodes draining intestinal segments were determined anatomically by following the lymphatic vessels connecting the colon, ileum and jejunum to their lymph nodes. Duodenal lymph nodes were revealed by gavaging 100 µl of olive oil (Sigma) and determining the most stomach-proximal lymph nodes surrounded by chyle, indicative of duodenal drainage, 2 h after gavage. Non-chylous stomachproximal lymph nodes (celiac and pancreatic) were excluded from total mLN analyses.
Cell sorting. Cells were sorted using a FACSAria cell sorter flow cytometer (Becton Dickinson). For mesenteric DC sorting, cells were preenriched using anti-CD11c MACS beads (Miltenyi Biotec) and LS MACS Separation Columns (Miltenyi Biotec). DCs were sorted as Aqua − CD45 + Li n − (CD3 − B220 − NK1.1 − CD19 − ) CD11c hi , and the subpopulations further as MHCII int CD8α + CD11b lo , MHCII int CD8α − CD11b + , MHCII hi CD103 + CD11b − and MHCII hi CD103 + CD11b + . Naive CD4 + T cells were pre-enriched by negative selection using biotinylated anti-CD8α, anti-CD25, anti-CD11c, anti-CD11b, anti-TER-119, anti-NK1.1 and anti-B220 ( Supplementary Table 1 ) and anti-biotin MACS beads (Miltenyi Biotec) and sorted as Aqua − CD11c − C D8α − MHCII − Vα2 + CD4 + CD25 − CD62 hi CD44 lo .
Flow cytometry. Cell populations were stained with Aqua in PBS, followed by incubation with Fc block and antibodies to the indicated cell surface markers ( Supplementary Table 1 ) in FACS buffer (PBS, 1% BSA, 10 mM EDTA, 0.02% sodium azide). The cells were analyzed live, or fixed in 1% PFA in PBS. For Foxp3-staining analysis, surface staining was followed by permeabilization using Foxp3 Mouse Regulatory T cell Staining Kit (eBioscience). Flow cytometry data were acquired on a LSR-II flow cytometer (Becton Dickinson) and analyzed using FlowJo software package (Tri-Star). Cell division index was calculated using the FlowJo formula (http://www.flowjo.com/v765/en/ proliferation.html), whereby the index represents the fraction of total cell divisions over the calculated total starting cells. Note that calculation of the division index is based on cells present at the time of analysis and cannot take into account potential lack of survival of CD45.1 cells in zDC DTR chimeras. Lineage contributions to APC pools (Fig. 4a,b) were calculated on the assumption that DT-mediated depletion was 100% efficient, as follows: first, we determined the frequency of each APC subpopulation in DT-treated wildtype mice; next, we determined the frequency of each subpopulation in DTtreated zDC DTR (and MM DTR ) chimeric mice; and finally, because depletion is not 100% and every mouse has slightly different APC subpopulation ratios (routinely ±5% for all cDC populations), we calculated the relative contribution for cDC-(or MM-) targeted to the wild-type levels to draw pie charts. BM chimeras. BM recipients were irradiated with two doses of 525 rads 3 h apart, and received 2 × 10 6 to 5 × 10 6 BM cells by retro-orbital injection under isoflurane anesthesia. BM chimeras were reconstituted for a minimum of eight weeks after irradiation before the start of their experimental use. Germ-free BM recipients were exported and irradiated in a sterile container, injected under a sterile hood and re-imported into sterile isolators. Mice tested negative for contamination 4 weeks after re-import and at the end of the experiments. For studies comparing Irf8 fl/fl and zDC(∆Irf8) BM recipients, the Irf8 fl/fl BM was obtained from the pure Irf8 fl/fl strain.
DT administration. The first dose of DT (D0564; Sigma) was delivered intraperitoneally as 500 ng in 200 µl PBS per 20 g body weight followed by one or two doses of 100 ng in 200 µl PBS per 20 g body weight, as indicated. Depletion efficiency was monitored in each animal by the serum Flt3L surge upon cDC depletion (zDC DTR chimeras) and the loss of blood monocytes 24h after DT administration in MM DTR chimeric mice.
Anti-Flt3L ELISA. Serum concentrations of Flt3L were determined using an anti-Flt3L ELISA kit (R&D Systems) according to the manufacturer's protocol. Sera were diluted 1:4 to be in range of the standard curve.
Oral antigen administration. OVA (grade III; A5378; Sigma) was administered at 50 mg in 200 µl PBS by gavage using metal gavage needles. 125 Iodine labeling of ovalbumin and 125 I-OVA uptake and clearance analysis. OVA grade VII (A7641; Sigma) was labeled with 125 Iodine (Perkin-Elmer) under a fume hood. 250 µCi Na 125 I in 135.5 µl 0.1 N NaOH was prepared and immediately mixed with an equal volume of 0.1 N HCl containing 6.67 nmol ICl. The iodine mixture was immediately added to 1 ml of 100 µg npg OVA in 1M glycine, pH 9.5, 100 mM NaCl (2.26 µM OVA, equivalent to an iodine/OVA molar ratio of 3:1), and the solution was incubated at RT for 10 min. Unincorporated iodine was removed by purification of the sample on two consecutive NAP25 columns (GE Healthcare). 125 I-OVA was eluted in H 2 O and kept at 4 °C in 1× PBS by appropriate addition of 10× PBS. Amount of labeling was determined on a Packard Cobra gamma counter and an estimated to be 95,000 c.p.m./µg OVA. Protein purity and integrity were confirmed on a Coomassie-stained gel and specific labeling of OVA was confirmed by exposure of the gel to autoradiography film. To determine OVA uptake and clearance, mice were fasted for 3 h and then gavaged at 12 p.m. with 50 mg OVA grade III in 200 µl PBS and 300,000 counts per minute of 125 I-OVA (about 4 µg OVA). Submandibular blood and urine were collected in 5 µl aliquots; whole organs were taken at indicated time points and weighed. Radioactivity was measured using on a Packard Cobra gamma counter.
CFA immunization and subcutaneous ear challenge. Eight days after oral OVA gavage, CFA-OVA was administered subcutaneously between the shoulder blades as an emulsion of 100 µl CFA and 100 µl PBS containing 300 µg endotoxin free OVA (EndoGrade Endotoxin-free Ovalbumin; 321000; HYGLOS) under isofluorane gas anesthesia. The first ear challenge was performed 14 d after immunization. 2.5 mg/ml endotoxin free OVA was heat-aggregated in PBS at for 2 h at 65 °C, and 30 µl of OVA (left ear) or PBS vehicle (right ear) were injected under isofluorane gas anesthesia. Ear thickness was measured using a digital precision caliper (Fisher Scientific). Swelling was determined by first subtracting pre-challenge from post-challenge ear thickness, and then subtracting the swelling upon PBS injection from swelling upon OVA injection.
Alum immunization and airway challenge. Eight days after oral OVA administration, 4 µg of endotoxin-free OVA antigen adsorbed to 40 µl Imject Alum Adjuvant (Fisher Scientific) was injected intraperitoneally in a final volume of 400 µl made up with PBS. Immunization was repeated after 7 d. To induce airway inflammation, mice were anesthetized and intranasally administered 10 µg of endotoxin-free OVA in 50 µl PBS (25 µl per nostril) on days 14, 17 and 21 after the first intraperitoneal immunization.
Bronchoalveolar lavage, lung histology and infiltrate analysis by flow cytometry.
Mice were anesthetized by intraperitoneal injection of 0.35 ml of 2.5% avertin (Sigma), the trachea was cannulated and lungs were lavaged once with 0.5 ml and then 1.0 ml PBS. Total BAL cells were counted after erythrocyte lysis and were stained for flow cytometry (antibodies, Supplementary  Table 1 ). Lungs were perfused via the right ventricle with 10 ml saline to wash out residual blood. One lobe was digested in 400 U/ml collagenase D/HBSS and processed for flow cytometry. Eosinophils were determined as CD45 + SSA hi MHCII − CD11b + Ly6G int SiglecF + . Another lobe was fixed with 4% phosphate-buffered formalin and embedded in paraffin. Tissues sections were stained with hematoxylin and eosin to determine cellular inflammation. Sections where assessed in a blinded fashion. An score was created for infiltration observed in a 1-cm 2 section: 0 = no infiltration, 1 = very mild infiltration, 2 = mild infiltration, 3 = locally severe infiltration, 4 = uniformly severe infiltration, 5 = uniformly very severe infiltration.
Anti-OVA IgG1 and IgG2c ELISA. High-binding ELISA 96-well plates (Corning, 3690) were coated with 50 µl of 20 µg/ml OVA grade II in 100 mM Na 2 CO 3 overnight at 4 °C. Plates were washed three times PBS plus 0.05% Tween 20 (PBS-T; Sigma), and blocked with 150 µl 1% BSA in PBS-T for 2 h at RT. Mouse serum was obtained by submandibular bleeding and was diluted in blocking buffer and added as 25 µl/well. For anti-OVA IgG1 ELISA quantification, an anti-OVA IgG1 (BioLegend) standard curve ranging from 0.125 ng/ml to 8 ng/ml was applied; for anti-OVA IgG2c ELISA quantification, a hyper-immune serum was diluted ranging from a 1:7,500 dilution (set as 1.0) to 1:480,000 dilution (set as 0.0156). Serum was assessed in duplicate and at two dilutions, typically 1:500,000 and 1:2,000,000 for the anti-IgG1 ELISA, and 1:5000 and 1:20,000 for the anti-IgG2c ELISA. Standards and test serum were incubated for 1 h at RT and the plates washed three times in wash buffer. Biotinylated anti-IgG1 or anti-IgG2c (Supplementary Table 1 ) was applied as 50 µl at 20 ng/ml in blocking buffer, and the plates incubated for 1 h and washed four times. Horseradish peroxidase-linked streptavidin (HRP-streptavidin) was added as 50 µl at 40 ng/ml and the plates incubates for 45 min at RT and then washed five times. Fifty µl HRP substrate TMB was added and the reaction stopped by the addition of 50 µl 1 N H 2 SO 4 . Plates were 'read' as absorbance at 450-570 nm. Absolute concentrations of anti-OVA IgG1 were determined from the standard curve; relative concentrations of anti-OVA IgG2c were determined by division of the concentrations determined by the standard curve by 4,800.
